Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
600 participants
OBSERVATIONAL
2017-01-01
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Facilitators and Barriers in Anorexia Nervosa - Treatment Initiation
NCT03713541
Comparison of Two Types of Family Therapy in the Treatment of Adolescent Anorexia Nervosa
NCT00610753
Family Functioning and Adverse Side Effects of Family-based Therapy for Anorexia Nervosa
NCT06097247
Experiences From Pregnancy and Post-partum Period in Women With a History of Eating Disorders.
NCT04815044
Family Therapy and Anorexia Nervosa : Which is the Best Approach?
NCT03350594
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Outcome measures The SCL-90-R questionnaire is a self-report inventory for adolescents and adults that assesses a wide range of psychological problems and symptoms of psychopathology. The questionnaire consists of 90 items, each of which contributes to one of nine primary symptom dimensions.
The short form of the Inventory of Interpersonal Problems (IIP-C) is used to measure interpersonal problems. This self-report questionnaire contains 64 items assigned to eight subscales.
Eligible candidates are stratified as cases or matched controls as follows:
1. Cases are eligible patients diagnosed with anorexia nervosa or bulimia nervosa (n=300 for each entity) at the time of study inclusion.
2. Controls (100) are healthy subjects of a similar age distribution and from the same study site without the diagnosis of an eating disorder.
Inclusion criteria:
\- Age \> 12 and \< 59 years (adolescents and adults).
Exclusion criteria:
* Diagnosed with a malignant disease
* Not fluent in the German language
* Severe mental disorder
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Psychotherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Not fluent in the German language
* Severe mental disorder
12 Years
59 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medical Center Goettingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Thomas Meyer
Head of Laboratory
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Meyer
Role: PRINCIPAL_INVESTIGATOR
University of Göttingen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Göttingen
Göttingen, NDS, Germany
University Medical Center
Göttingen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Thomas Meyer, Prof.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
32/1/17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.